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PObesity and the Heart
Obesity Induces Signs of Premature
Cardiac Aging in Younger Patients
The Role of Mitochondria
Bernd Niemann, MD,*†‡ Ying Chen, MD,† Mirja Teschner, MD,* Ling Li, MD,†§
Rolf-Edgar Silber, MD,* Susanne Rohrbach, MD†§
Halle and Giessen, Germany
Objectives The purpose of the present study was to investigate the influence of obesity on cardiac aging.
Background Obesity is associated with an increased incidence of left ventricular hypertrophy, diastolic dysfunction, heart fail-
ure, and atherosclerosis.
Methods Sixty male cardiac surgery patients were included in the study according to body mass index (18.5 to 25 kg/m2:
normal weight; 30 to 35 kg/m2: obese) and age (55 years: young; 70 years: old) and divided into 4 groups
of 15 patients each. Right atrial cardiomyocytes were analyzed for mitochondrial function, markers of apoptosis,
cardiac load or metabolism, and oxidative stress parameters. The metabolic state was further characterized in
fasting blood samples.
Results Obesity resulted in disturbed mitochondrial biogenesis and function (respiratory chain complex I) in the cardio-
myocytes of young and old patients. Disturbed mitochondrial function was associated with signs of increased
oxidative stress (protein carbonyl content, 8-hydroxy-2=-deoxyguanosine) as well as telomere shortening by up to
30%. Cardiomyocytes from older (obese and normal-weight) and young obese patients demonstrated higher lev-
els of load-induced markers (atrial natriuretic peptide and brain natriuretic peptide) and proapoptotic activation
with increased Bax and Bcl-xS expression, cytochrome C release, and caspase 3/9 activation. Disturbances in
glucose metabolism and adipocytokine release were detectable in old (obese and normal-weight) and young
obese patients. However, only minor deteriorations in most parameters were observed in obese subjects older
than 70 years of age compared with normal-weight, age-matched patients.
Conclusions These data indicate that obesity results in premature cardiac aging in younger patients, which may contribute to
an increased risk for heart failure. (J Am Coll Cardiol 2011;57:577–85) © 2011 by the American College of
Cardiology Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2010.09.040a
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sn adults, obesity, defined by a body mass index (BMI)30
g/m2, is associated with an increased risk for death (1).
besity has become a global epidemic and is now recog-
ized as a risk factor for multiple chronic diseases, including
ardiac diseases. In Western society, cardiac surgeons are
acing increasingly obese and old patients displaying ele-
ated perioperative risk. Therefore, the need for strategies
or risk analysis and risk reduction in these patients has
rom the *Department of Cardiothoracic Surgery, Martin Luther University Halle-
ittenberg, Halle, Germany; †Institute of Pathophysiology, Martin Luther Univer-
ity Halle-Wittenberg, Halle, Germany; ‡Department of Cardiac and Vascular
urgery, Justus Liebig University, Giessen, Germany; and the §Institute of Physiol-
gy, Justus Liebig University, Giessen, Germany. This study was supported by grant
O 2328/2-1 from Deutsche Forschungsgemeinschaft, grant F/05/05 from Deutsche
tiftung für Herzforschung, and grants FKZ:14/42, FKZ:14/30, and FKZ:12/39
rom the Wilhelm Roux Program of the Medical Faculty Halle. The authors have
eported that they have no relationships to disclose.t
Manuscript received February 5, 2010; revised manuscript received September 10,
010, accepted September 13, 2010.risen. The influence of overweight or underweight is
ontroversially discussed and not implemented in clinical
coring systems for the estimation of risk-adjusted surgical
utcomes, except for the Parsonnet score (2). Adverse
ardiac effects of obesity include left ventricular (LV)
ypertrophy, chronic volume overload, systolic and diastolic
ysfunction, left atrial enlargement with atrial fibrillation,
nd coronary artery disease (3). Reduction in body weight,
n contrast, has been shown to improve blood pressure,
nsulin sensitivity, and inflammatory parameters, including
he release of protective adipocytokines.
See page 586
Mitochondrial dysfunction, including mitochondrial loss
nd the production of reactive oxygen species (ROS), was
uggested to be involved in the development of insulin resis-
ance and the progression of aging. Consequently, many of the
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Obesity Causes Premature Cardiac Aging February 1, 2011:577–85observed phenotypic changes and
pathomechanisms in obesity are
also present in the aging heart.
The mitochondrial respiratory
chain is generally assumed to be
the main source of ROS (4). Sub-
sequently, increasing damage to
deoxyribonucleic acid (DNA),
proteins, or lipids accumulates
with age progression, and as a
consequence, an impairment of
cellular function may result. Respi-
ratory chain function decreases
with age, while oxidative damage
and mutations of mitochondrial
DNA (mtDNA) increase during
human aging. The unique role of
mitochondria-derived ROS in the
aging process has been shown re-
cently (5). Only mice with an
verexpression of catalase localized to the mitochondria, but
ot to the peroxisome or the nucleus, demonstrated an increase
n lifespan together with reductions in oxidative DNA damage
nd in age-associated cardiac pathology (5). Furthermore, mice
xpressing proofreading-deficient mtDNA polymerase gamma
ccumulate mtDNA mutations and show accelerated aging
ith increased apoptosis (6). These data clearly show that
itochondrial dysfunction and the accumulation of mtDNA
utations are central mechanisms in the induction of apoptosis
nd mammalian aging.
Therefore, in the present study, we evaluated whether
ardiomyocytes from younger patients with obesity show
olecular signs of premature aging together with premature
etabolic disturbances and mitochondrial dysfunction.
ethods
tudy design. Sixty male patients undergoing coronary
rtery bypass graft surgery were included in the study.
ubjects were grouped according to BMI (18.5 to 25 kg/m2:
ormal weight; 30 to 35 kg/m2: obese) and age (55 years:
oung;70 years: old) into 4 groups (young normal weight,
oung obese, old normal weight, and old obese), with 15
atients in each group. Patients with pre-existing diabetes
ellitus (fasting glucose 120 mg/dl or use of diabetes
edications), reduced LV function (ejection fraction
55%), histories of arrhythmia, or enlarged atria were not
onsidered for study participation. Pre-surgical testing
electrocardiography, echocardiography, and coronary an-
iography) was performed in all patients. Fasting blood
amples were obtained before surgery and in the course of
reatment from each patient. Right auricular tissue was
btained during cannulation of the right atrium in prepa-
ation for cardiopulmonary bypass. The study was approved
y the local ethics committee, and informed written consent
Abbreviations
and Acronyms
ANP  atrial natriuretic
peptide
BMI  body mass index
DNA  deoxyribonucleic
acid
LV  left ventricular
mRNA  messenger
ribonucleic acid
mtDNA  mitochondrial
deoxyribonucleic acid
NT-BNP  N-terminal brain
natriuretic peptide
ROS  reactive oxygen
species
ZDF  Zucker diabetic
fattyas obtained from each patient before surgery. wnimal model. Obesity-associated changes were also ana-
yzed in adult atrial and ventricular cardiomyocytes from
bese Zucker diabetic fatty (ZDF) (fa/fa) rats and lean
ild-type rats (Charles River Laboratories, Wilmington,
assachusetts). In ZDF rats with loss-of-function muta-
ions in their leptin receptors, the onset of obesity occurs at
weeks of age, while at 12 weeks of age, overt diabetes
egins. In this study, we used animals age 8 weeks. Obese,
ondiabetic ZDF (fa/fa) rats show body weights approxi-
ately 20% higher than wild-type rats at this age.
tatistical analysis. All values of numeric parameters are
xpressed as mean  SD unless otherwise stated. Statistical
nalysis of differences observed between numeric parameters
f all groups was performed using 1-way analysis of variance
sing an all pairwise multiple comparison procedure
Tukey’s test) for correction (4 groups, equal sample num-
ers). Targets were specified a priori. Nominal variables were
ompared using Pearson’s chi-square test. Statistical signifi-
ance was accepted at the level of p 0.05. Statistical analysis
as performed using SigmaStat for Windows version 3.5
Systat Software Inc., Chicago, Illinois). Further details on all
ther methods are provided in the Online Appendix.
esults
atient characteristics. Systolic and diastolic blood pressure
as increased in obese patients compared with age-matched
ormal-weight subjects, but ejection fraction did not demon-
trate any differences. The predicted perioperative risk by the
uropean System for Cardiac Operative Risk Evaluation and
CH 2.0 Score (a German system for coronary surgery risk
valuation according to the Federal Agency of Quality Man-
gement) increased significantly with age but was independent
f elevated BMI. Both waist circumference and waist-to-hip
atio reached comparable pathological levels in both groups of
bese patients (Table 1). Operative procedures (clamp time,
umber of grafts) did not differ between the groups. Mean
ntensive care unit length of stay (not shown) and ventila-
ory support time were significantly higher in older patients.
he total time of hospitalization, however, was increased in
ld patients (normal weight and obese) as well as in young
bese patients. Maximal post-operative C-reactive protein
as elevated in young and old obese patients. Atrial fibril-
ation was observed only in older patients, and death
ccurred in young obese (n  1) and old obese (n  2)
atients only (Table 1). Although LV ejection fraction
emonstrated normal values echocardiographically, plasma
-terminal brain natriuretic peptide (NT-BNP) (Table 2)
nd atrial natriuretic peptide (ANP) messenger ribonucleic acid
mRNA) (Fig. 1A) were elevated in both groups of old patients
normal weight and obese) as well as in young obese patients.
besity induces metabolic disorder in young obese patients.
ld patients (normal weight and obese) and young obese
ubjects displayed higher fasting glucose, insulin, and leptin
lasma levels (Table 2) compared with the young normal-
eight group. However, fasting glucose, insulin, and glyco-
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February 1, 2011:577–85 Obesity Causes Premature Cardiac Agingylated hemoglobin were below the threshold required for
he diagnosis of type 2 diabetes mellitus, and the homeosta-
is model assessment of insulin resistance index was only
inimally higher than 2.5 in young and old obese patients.
levation in retinol-binding protein-4 was shown to occur
efore the development of manifest diabetes mellitus (7). In
ur study, both groups of obese patients (young and old)
howed elevated plasma retinol-binding protein-4 (Table
). The adipocytokine adiponectin, in contrast, which di-
ectly sensitizes the body to insulin, was decreased in the
Clinical ParametersTable 1 Clinical Parameters
Variable
Young Normal Weight
(n  15)
Age (yrs) 50.4 5.8
BMI (kg/m2) 24.5 1.2
Waist circumference (cm) 88.2 1.9
Waist-to-hip ratio 0.85 0.11
RR systolic (mm Hg) 127.2 9.6
RR diastolic (mm Hg) 73.1 4.6
Ejection fraction (%) 61.1 10.1
Atrial fibrillation 0
KCH 2.0 score 0.6 0.4
EuroSCORE 2.2 1.9
Parsonnet score (%)§ 4.3 5.0
Grafts 2.7 0.8
Total hospitalization (days) 12.4 1.9
Ventilatory support (h) 13.5 14.7
Deaths 0
Preoperative medications
Beta-blockers 6
Diuretic agents 2
Antiarrhythmic agents 0
ACE inhibitors/ARBs 8
Anticoagulant agents 15
Nitrates 8
Lipid-lowering agents 6
Data are expressed as mean  SD or n. Clinical parameters including
young normal-weight patients. †p  0.05 versus old normal-weight pa
mortality.
ACE angiotensin-converting enzyme; ARB angiotensin receptor
Operative Risk Evaluation.
lasma ParametersTable 2 Plasma Parameters
Variable
Young Normal Weight
(n  15)
Glucose (mg/dl) 81.0 39.9
Insulin (IU/ml) 6.0 8.1
HbA1c (%) 4.9 3.1
HOMA-IR 1.3 1.2
Adiponectin (g/ml) 46.4 15.9
Leptin (ng/ml) 6.9 18.9
RBP-4 (mg/l) 33.9 16.6
NT-proBNP (pmol/l) 16.3 5.8
Post-operative maximal CRP (mg/l) 205.9 103.7
ata are expressed as mean  SD. All values except CRP were measured in pre-operatively obtain
atients. ‡p  0.051 versus young normal-weight patients.
CRP  C-reactive protein; HbA1c  glycosylated hemoglobin; HOMA-IR  homeostasis model asse
etinol-binding protein-4.lasma of old (normal weight and obese) as well as young
bese patients (Table 2). Accordingly, cardiomyocytes,
hich have been demonstrated to express significant
mounts of adiponectin (8), showed reduced expression of
diponectin mRNA and fasting-induced adipose factor
RNA (Fig. 1B) in these 3 groups (young obese and old
ormal-weight and obese subjects).
omparable effects in atrial and ventricular cardiomyocytes
rom obese rats. It has yet to be evaluated whether changes
bserved in human right atrial cardiomyocytes from obese
ung Obese
(n  15)
Old Normal Weight
(n  15)
Old Obese
(n  15)
1.1 4.2 77.2 2.7 74.8 2.7
5.0 3.5 24.1 1.5 32.6 1.5
2.4 2.3* 86.5 3.5 104.7 2.3†
.08 0.19* 0.86 0.11 1.11 0.08†
1.4 15.1* 134.3 17.8‡ 148.7 17.4†
0.5 7.0* 72.1 5.8 79.3 6.6†
2.6 9.3 59.2 12.4 59.4 7.7
0 2 2
0.5 0.4 1.5 0.8* 1.4 0.8
1.7 0.8 6.7 2.7* 5.2 3.1
2.6 2.3 12.9 8.1* 7.5 4.6†
2.9 0.8 2.5 1.2 2.7 0.8
7.8 7.4* 14.8 3.1 17.6 8.1
1.8 5.8 29.5 15.9* 38.7 23.2
1 0 2
7 10 9
4 8* 12
1 2 2
9 11 9
14 15 13
6 7 5
8 9 13
for risk evaluation were registered before surgery. *p  0.05 versus
‡p  0.051 versus young normal-weight patients. §Predicted 30-day
; BMI body mass index; EuroSCORE European System for Cardiac
Young Obese
(n  15)
Old Normal Weight
(n  15)
Old Obese
(n  15)
104.7 47.9* 108.8 32.8* 106.9 52.2
10.9 13.5* 9.3 8.5* 10.6 17.8
5.7 5.0 5.4 3.5 5.9 6.2
2.6 2.3* 2.4 2.7* 2.6 0.8
22.5 17.0‡ 16.5 15.5‡ 16.4 12.4
44.2 43.7‡ 38.4 26.7‡ 42.9 17.8
57.3 31.7* 39.4 15.9 51.7 19.3†
32.5 11.2* 33.9 10.0* 34.8 8.5
243.1 73.1* 208.2 85.5 246.3 74.3†
d samples. *p  0.05 versus young normal-weight patients. †p  0.05 versus old normal-weightYo
5
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Obesity Causes Premature Cardiac Aging February 1, 2011:577–85atients reflect the situation in the ventricles. However, the
vailability of specimens from human ventricles is extremely
imited. Therefore, we evaluated selected parameters in-
icating obesity-associated premature aging in a rat
odel of obesity. As shown in Online Figure 1A, ANP
RNA expression was increased in atrial and ventricular
ardiomyocytes from obese rats, while only minor
hanges in brain natriuretic peptide were observed. Pro-
poptotic Bax and Bcl-xS mRNA were increased, while
itochondrial ND6 and Tfam were significantly reduced
n atrial as well as ventricular myocytes from obese rats
Online Figs. 1B and 1C). This indicates that results
btained from atrial myocytes closely reflect the situation
n ventricular myocytes for these parameters. Thus,
uman atrial tissue represents a valuable and available
ource for such analyses.
isturbed mitochondrial function and increased oxidative
tress in young obese patients. Alterations in mitochon-
rial function and number have long been associated with
etabolic disorders, and they are also involved in regulating
ifespan. Therefore, we speculated that young obese patients
ay demonstrate signs of disturbed mitochondrial function
nd biogenesis. Indeed, the mRNA expression of 2 key
ranscriptional regulators involved in the mitochondrial
iogenic response (Tfam and nuclear respiratory factor-1)
Fig. 2A) as well as protein and mRNA expression of the
rimary mitochondrial transcript ND6 (complex I of the
Figure 1 Obesity and Aging Alter mRNA Expression
of Load-Induced Genes and Adipocytokines
Messenger ribonucleic acid (mRNA) expression of (A) atrial natriuretic peptide
(ANP) and brain natriuretic peptide (BNP) and (B) the adipocytokines adiponec-
tin and fasting-induced adipose factor (FIAF) in adult cardiomyocytes, as deter-
mined by quantitative real-time polymerase chain reaction. Data are expressed
as mean  SEM; n  15 per group. rRNA  ribosomal ribonucleic acid. p 
0.05. p  0.01.espiratory chain) (Fig. 2B) were strongly reduced in old cnormal-weight and obese) and young obese subjects. Per-
xisome proliferator–activated receptor-gamma coactivator
-alpha mRNA (Fig. 2A) and nuclear respiratory factor-2
RNA (not shown) were not altered in any of the groups.
he nuclear transcript NDUFB8, which also encodes a
omplex I protein, was reduced at the mRNA level in these
roups too, while NDUFB8 protein demonstrated only
inor differences (Fig. 2C). Disturbed mitochondrial bio-
enesis may result in altered mitochondrial function. In-
eed, photometric enzymatic measurements in right atrial
issue demonstrated a significant reduction in complex I
nzyme activity in old (normal-weight and obese) and
oung obese subjects, with the lowest enzyme activities in
he old obese (Fig. 2D). Complex II (Fig. 2D), which
ontains only proteins encoded by the nuclear genome, was
ot altered, and nor were complexes III to V (not shown).
hus, young obese patients demonstrated signs of disturbed
itochondrial function and biogenesis otherwise seen only
n old patients.
Alterations in mitochondrial function are associated with
ncreased mitochondrial radical formation with a major impact
n the aging process, as shown previously (5). Accordingly,
arkers of oxidative stress (protein carbonyl content and
xidative DNA damage/8-hydroxy-2=-deoxyguanosine) were
ignificantly higher in cardiomyocytes isolated from old
normal-weight and obese) and young obese subjects, with the
ighest values in the old obese (Figs. 3A and 3B). Telomere
ength is a sensitive indicator of cumulative oxidative stress in
ost-mitotic cells and has been implicated in senescence and
poptotic signaling. Accordingly, mean telomere length was
educed up to 30% in cardiomyocytes of old (normal-weight
nd obese) and young obese subjects, with the shortest telo-
eres in the old obese (Fig. 3C).
yocardial apoptosis in young obese patients. The ac-
umulation of oxidative mtDNA damage that promotes
poptosis was suggested to be a central mechanism driving
ammalian aging (6). In the present study, we observed
ncreased mRNA expression in proapoptotic Bcl-2 family
embers (Bax and Bcl-xS) (Fig. 4A) in cardiomyocytes
rom old (normal-weight and obese) and young obese
ubjects, while no change was observed for the antiapoptotic
cl-xL and Bcl-2 mRNA (not shown). The proapoptotic
rotein Bcl-xS and the antiapoptotic protein Bcl-xL are
roducts of the Bcl-x gene, originating from alternative
plicing (9). Reduced Bcl-xL and increased Bcl-xS protein
xpression, resulting in minor changes in the Bcl-xS/Bcl-xL
atio (Fig. 4B), were observed in young obese patients.
rotein expression of Bcl-xL was strongly reduced and
cl-xS protein induced in old (normal-weight and obese)
atients, resulting in increased Bcl-xS/Bcl-xL ratios (Fig. 4B)
ompared with young normal-weight patients. A similar
ncrease in Bax protein was observed (Fig. 4B). In these 3
roups (old normal-weight and old and young obese sub-
ects), several parameters indicated partial apoptotic activa-
ion: release of cytochrome C into cytosol, reduced pro-
aspase 9 and procaspase 3, and caspase 9 cleavage products
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February 1, 2011:577–85 Obesity Causes Premature Cardiac AgingFig. 4C), comparable with alterations observed in failing
uman myocardium previously (10).
iscussion
lthough age-associated deteriorations in mitochondrial
Figure 2 Obesity and Aging Reduce Mitochondrial Biogenesis a
Messenger ribonucleic acid (mRNA) expression of (A) Tfam, peroxisome proliferator–a
(NRF-1) and (B) complex I proteins ND6 (mitochondrial encoded) and NDUFB8 (nuclea
tive Western blots of ND6 and NDUFB8 in adult cardiomyocytes. n  15 per group. (D
NADH:CoQ1 oxidoreductase) and complex II and III activity in right atrial tissue. n  8
p  0.001. ON  old normal-weight subjects; OO  old obese subjects; rRNA  r
subjects.unction and proapoptotic activation in cardiomyocytes have oeen shown prevoiusly, this study is the first to demonstrate
hat such changes occur at younger ages in obese patients.
urthermore, oxidative DNA or protein damage and higher
lasma NT-BNP are detectable in young obese patients
ven without manifest heart failure. This suggests that
nzyme Activity
d receptor-gamma coactivator 1-alpha (PGC-1), and nuclear respiratory factor-1
ded) in adult cardiomyocytes. n  15 per group. (C) Quantification and representa-
te synthase (CS) normalized respiratory chain complex I activity (rotenone-sensitive
up. Data are expressed as mean  SEM. ()p  0.051. p  0.05. p  0.01.
al ribonucleic acid, YN  young normal-weight subjects; YO  young obesend E
ctivate
r enco
) Citra
per gro
ibosombesity induces a phenotype of premature cardiac aging in
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Obesity Causes Premature Cardiac Aging February 1, 2011:577–85ounger patients, which is likely to result in the deteriora-
ion of cardiovascular function if overweight persists.
linical scores and the obesity paradox. Despite the
trong association of obesity with numerous cardiovascular
omorbidities, studies have documented that moderate obe-
ity is associated with better outcomes in patients with heart
ailure, compared with patients with normal weight (termed
he obesity paradox). Indeed, a “U-shaped” outcome curve
ccording to BMI may exist, in which mortality is greatest
n underweight patients, lower in mildly obese patients, but
igher again in more severely overweight patients (11).
imilarly, in cardiac surgery, the impact of obesity as an
ndependent risk factor for perioperative mortality is still
nder discussion. Recent studies have suggested a negative
12) or positive (13) influence of BMI on operative mortal-
ty. However, in some of these studies, the mean age of
ormal-weight patients was significantly higher than that of
bese subjects (13). Unlike age, BMI is not yet incorporated
nto clinical scoring systems as a predictor of adverse
utcome and mortality. Accordingly, clinical scores in the
resent study (the European System for Cardiac Operative
isk Evaluation [14], the KCH 2.0 score, and the Parson-
et score [2]) predicted increased operative risk for older
atients only. In fact, the Parsonnet score predicted signif-
cantly higher risk in old normal-weight subjects compared
Figure 3 Obesity and Aging Increase Oxidative Stress
Quantification of (A) oxidative protein damage (protein carbonyls), (B) oxidative
(C) telomere length and representative Southern blot from adult cardiomyocyte
mean  SEM; n  15 per group. p  0.05. p  0.01. Abbreviations as inith old obese subjects (Table 1). Indexes of abdominal tbesity and fat distribution such as waist-to-hip ratio were
uggested to represent more consistent and stronger predic-
ors of cardiovascular risk in obese patients than BMI.
ardiac ROS and apoptosis. According to the mitochon-
rial theory of aging, oxidative damage that results from
OS production during cellular respiration is a physiolog-
cal cause of aging (4). Most ROS in cardiomyocytes are
enerated by the respiratory chain, mainly at complexes I
nd III (15). ROS formation by the respiratory chain
ncreases when electron flow slows down (15). The signif-
cant reduction in complex I activity (Fig. 2) in old (normal-
eight and obese) and younger obese patients is therefore a
ikely source of increased ROS. Reduced complex I activity
s a common feature in heart failure (16), diabetes (17), and
ging (18). In addition to recently reported mitochondrial
isturbances in human right atrial tissue from patients with
ype 2 diabetes (19), we show here that young obese patients
how comparable mitochondrial dysfunction (Figs. 2 and 3),
ven in the absence of manifest diabetes (Table 2). MtDNA
utations are thought to have a causal role in age-related
athologies (6). In the present study, oxidatively damaged
NA and proteins accumulated in cardiomyocytes from young
bese patients (Fig. 3) to the same extent as in older patients.
ailing human hearts show up to 25% shorter telomeres, and
elomere dysfunction mediates the increased apoptotic rates
yribonucleic acid (DNA) damage (8-hydroxy-2=-deoxyguanosine [8-OHdG]), and
luding a digoxigenin-labeled molecular weight marker. Data are expressed as
2.deox
s, inc
Figureypically observed in failing myocytes (20). However, the
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February 1, 2011:577–85 Obesity Causes Premature Cardiac Agingumber of actively dividing cardiomyocytes is minimal at best.
hus, telomere attrition cannot be explained by the “end-
eplication” problem but suggests telomere erosion due to
xidative damage. Aging and obesity were both associated
ith a significant reduction of telomere length in our patients
Fig. 3), which may have contributed to elevated apoptotic load
n these subjects (Fig. 4). These 3 groups of patients (old
ormal-weight and old and young obese patients) showed
ytochrome C release and partially activated caspase cascade
caspase 3 and 9), which is similar to alterations observed in
ailing human myocardium (10). Furthermore, the increase in
roapoptotic Bax and Bcl-xS and reduction in antiapoptotic
cl-xL (Fig. 4) emphasize the major role of mitochondrially
ediated apoptotic mechanisms in these patients. In cultured
eonatal rat cardiomyocytes, interference with Bcl-x splicing
oward enhanced Bcl-xS and reduced Bcl-xL expression causes
itochondrial dysfunction, enhances ROS release, and triggers
poptosis (21).
ardiac function and metabolism. Despite echocardio-
raphically normal LV function (ejection fraction 55%),
lasma NT-BNP (Table 2) and right atrial ANP mRNA
xpression (Fig. 1) were increased in young obese patients
nd older patients (normal weight and obese). A similar
issociation between increased ANP mRNA and plasma
Figure 4 Obesity and Aging Result in Proapoptotic Activation
(A) Messenger ribonucleic acid (mRNA) expression of proapoptotic genes Bax and
chain reaction. Quantification and representative Western blots of (B) Bcl-xS/L an
cytes. Data are expressed as mean  SEM; n  15 per group. ()p  0.050. pT-BNP but only marginally elevated BNP mRNA as rbserved here was shown in rat compensated heart failure
22). Obese patients (young and old) presented increased
ystolic and diastolic blood pressure, which may have caused
he rise in natriuretic peptides. The mean NT-BNP value
Table 2) reported in young obese patients (32.5 pmol/l 
75 pg/ml) is less than the approved cutoff value for the
iagnosis of congestive heart failure (300 pg/ml). How-
ver, even the mildly obese state was reported to be associated
ith a significantly increased risk for heart failure (23).
Plasma analyses demonstrated increased insulin, glucose,
nd leptin together with lower adiponectin in both groups
f obese patients (Table 2). However, plasma glycosylated
emoglobin, which is also used to predict the likelihood that
atients will develop diabetes in the future, was similar in all
roups and did not show values higher than 6% (Table 2).
he low adiponectin and fasting-induced adipose factor
RNA (Fig. 1) in young obese and older patients suggests
imilar regulatory mechanisms in response to nutritional
nd age-related changes. A corresponding induction of both
enes (24,25) can be observed under fasting conditions, and
ge-associated low levels of the endogenous insulin sensi-
izer adiponectin have also been shown previously (24).
urthermore, adiponectin was suggested to represent the
ajor link between imbalanced adipokine profiles and atrial
in adult cardiomyocytes, as determined by quantitative real-time polymerase
and (C) cytosolic cytochrome C, caspase 9, and caspase 3 in adult cardiomyo-
. p  0.01. p  0.001. Abbreviations as in Figure 2.Bcl-xS
d Bax
 0.05emodeling (26), and obesity was shown to be the main risk
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ntiatherogenic properties, adiponectin has direct beneficial
ffects on cardiomyocytes in several pathological heart
onditions, including cardiac hypertrophy and ischemia-
eperfusion injury. These are mainly mediated via the
denosine monophosphate–activated protein kinase and
esult in attenuated inflammatory response and decreased
yocyte death (28). In addition, direct protective effects of
ardiomyocyte-derived adiponectin (8) on myocardial
schemia-reperfusion injury were shown recently (29), and
diponectin is also involved in the adenosine monophos-
hate–activated protein kinase–mediated regulation of mi-
ochondrial biogenesis (30). Restoration of adiponectin
ignaling by weight loss was shown to contribute to the
ecovery of LV function after ischemia-reperfusion and to
imit infarct size (31). These findings suggest that both
at-derived and cardiomyocyte-derived adiponectin are es-
ential for cardiomyocyte survival and mitochondrial func-
ion. Low adiponectin (Table 2, Fig. 1) may thus have
ontributed directly to mitochondrial dysfunction and pro-
poptotic activation in right atrial cardiomyocytes from
oung obese and old (normal weight and obese) patients.
Our data show that obesity at younger ages, even in the
bsence of manifest glucose intolerance, is associated with
ajor imbalances in adipocytokine profiles, resulting in
isturbances in cardiomyocyte survival and function. How-
ver, no further deterioration is observed in patients older
han 75 years of age with a comparable degree of obesity.
he basic mechanisms of lipotoxicity were reported to be
onserved among species (32). The present study confirms
he previous observation in rat and human tissue. Further-
ore, our study shows that obesity-associated effects on
oad-induced, apoptotic, and mitochondrial genes observed
n rat atrial cardiomyocytes reflect the situation in the
entricles. Considering the difficulties in obtaining human
entricular specimens, the analysis of human right atrial
issue represents a valuable alternative.
tudy limitations. It is difficult to establish a causal rela-
ionship in a rather complex biologic system with multiple
nteractions using the present study design and a small
ample size. Although the age difference between younger
nd older patients was more than 20 years on average,
atients younger than 50 years of age would be preferable.
owever, normal-weight patients at this age only rarely
resent for coronary artery bypass graft surgery.
onclusions
dentification of the underlying mechanisms leading to
remature cardiac aging together with premature meta-
olic disturbances and mitochondrial dysfunction in obe-
ity could contribute to the development of new thera-
eutic strategies. However, if data concerning BMI and
eight loss are to directly influence treatment recommen-
ations for patients with heart failure, well-designed
linical trials are needed.cknowledgment
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